These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12356750)

  • 1. Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines.
    Hurbin A; Dubrez L; Coll JL; Favrot MC
    J Biol Chem; 2002 Dec; 277(51):49127-33. PubMed ID: 12356750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines.
    Hurbin A; Dubrez L; Coll JL; Favrot MC
    Ann N Y Acad Sci; 2003 Dec; 1010():354-7. PubMed ID: 15033751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells.
    Hurbin A; Coll JL; Dubrez-Daloz L; Mari B; Auberger P; Brambilla C; Favrot MC
    J Biol Chem; 2005 May; 280(20):19757-67. PubMed ID: 15767261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphiregulin promotes BAX inhibition and resistance to gefitinib in non-small-cell lung cancers.
    Busser B; Sancey L; Josserand V; Niang C; Favrot MC; Coll JL; Hurbin A
    Mol Ther; 2010 Mar; 18(3):528-35. PubMed ID: 19826406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-1 receptor inhibition overcomes gefitinib resistance in mucinous lung adenocarcinoma.
    Hurbin A; Wislez M; Busser B; Antoine M; Tenaud C; Rabbe N; Dufort S; de Fraipont F; Moro-Sibilot D; Cadranel J; Coll JL; Brambilla E
    J Pathol; 2011 Sep; 225(1):83-95. PubMed ID: 21598249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphiregulin promotes resistance to gefitinib in nonsmall cell lung cancer cells by regulating Ku70 acetylation.
    Busser B; Sancey L; Josserand V; Niang C; Khochbin S; Favrot MC; Coll JL; Hurbin A
    Mol Ther; 2010 Mar; 18(3):536-43. PubMed ID: 19826407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers.
    Yonesaka K; Zejnullahu K; Lindeman N; Homes AJ; Jackman DM; Zhao F; Rogers AM; Johnson BE; Jänne PA
    Clin Cancer Res; 2008 Nov; 14(21):6963-73. PubMed ID: 18980991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of heparin-binding EGF-related peptides in proliferation and apoptosis of activated ras-stimulated intestinal epithelial cells.
    Zushi S; Shinomura Y; Kiyohara T; Miyazaki Y; Tsutsui S; Sugimachi M; Higashimoto Y; Kanayama S; Matsuzawa Y
    Int J Cancer; 1997 Dec; 73(6):917-23. PubMed ID: 9399676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib.
    Liu X; Carlisle DL; Swick MC; Gaither-Davis A; Grandis JR; Siegfried JM
    Exp Cell Res; 2007 Apr; 313(7):1361-72. PubMed ID: 17349623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gefitinib (Iressa, ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells.
    Kishida O; Miyazaki Y; Murayama Y; Ogasa M; Miyazaki T; Yamamoto T; Watabe K; Tsutsui S; Kiyohara T; Shimomura I; Shinomura Y
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):584-94. PubMed ID: 15723219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and Tgfalpha mediated transactivation of the epidermal growth factor receptor.
    Ogunwobi OO; Beales IL
    Br J Biomed Sci; 2008; 65(3):121-7. PubMed ID: 18986098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib.
    Desbois-Mouthon C; Cacheux W; Blivet-Van Eggelpoël MJ; Barbu V; Fartoux L; Poupon R; Housset C; Rosmorduc O
    Int J Cancer; 2006 Dec; 119(11):2557-66. PubMed ID: 16988945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase-dependent mechanism.
    Jeannot V; Busser B; Brambilla E; Wislez M; Robin B; Cadranel J; Coll JL; Hurbin A
    Int J Cancer; 2014 Jun; 134(11):2560-71. PubMed ID: 24374738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligands of epidermal growth factor receptor and the insulin-like growth factor family as serum biomarkers for response to epidermal growth factor receptor inhibitors in patients with advanced non-small cell lung cancer.
    Vollebergh MA; Kappers I; Klomp HM; Buning-Kager JC; Korse CM; Hauptmann M; de Visser KE; van den Heuvel MM; Linn SC
    J Thorac Oncol; 2010 Dec; 5(12):1939-48. PubMed ID: 21102259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increases of amphiregulin and transforming growth factor-alpha in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers.
    Ishikawa N; Daigo Y; Takano A; Taniwaki M; Kato T; Hayama S; Murakami H; Takeshima Y; Inai K; Nishimura H; Tsuchiya E; Kohno N; Nakamura Y
    Cancer Res; 2005 Oct; 65(20):9176-84. PubMed ID: 16230376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways.
    Janmaat ML; Kruyt FA; Rodriguez JA; Giaccone G
    Clin Cancer Res; 2003 Jun; 9(6):2316-26. PubMed ID: 12796401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gefitinib ("Iressa", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells.
    Kishida O; Miyazaki Y; Murayama Y; Ogasa M; Miyazaki T; Yamamoto T; Watabe K; Tsutsui S; Kiyohara T; Shimomura I; Shinomura Y
    Cancer Chemother Pharmacol; 2005 Apr; 55(4):393-403. PubMed ID: 15723263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco smoke-induced lung cell proliferation mediated by tumor necrosis factor alpha-converting enzyme and amphiregulin.
    Lemjabbar H; Li D; Gallup M; Sidhu S; Drori E; Basbaum C
    J Biol Chem; 2003 Jul; 278(28):26202-7. PubMed ID: 12711607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.
    Ono M; Hirata A; Kometani T; Miyagawa M; Ueda S; Kinoshita H; Fujii T; Kuwano M
    Mol Cancer Ther; 2004 Apr; 3(4):465-72. PubMed ID: 15078990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metalloprotease-dependent amphiregulin release mediates tumor necrosis factor-alpha-induced IL-8 secretion in the human airway epithelial cell line NCI-H292.
    Chokki M; Mitsuhashi H; Kamimura T
    Life Sci; 2006 May; 78(26):3051-7. PubMed ID: 16427093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.